Open Access Mini Review

Specific Treatment of Bone Metastases in Non-PC Urological Malignancies

Aleksandar Vuksanovic*

Clinical Centre of Serbia, Serbia

Corresponding Author

Received Date: January 30, 2019;  Published Date: February 13, 2019


Bones are common site for metastatic development, in fact the third most common site of metastases, right after lungs and liver. This tendency is explained with its microenvironment – specifically bone marrow, that tends to facilitate “thriving” of certain types of metastatic cancer cells, which usually originate from prostate, breast and lung. Prostate cancer in particular has proclivity for development of osseous metastases, where we commonly find that the bones are the only site of its secondary deposits [1].

Signup for Newsletter
Scroll to Top